The DOI matches its Crossref record; 149 of the 150 references it cites were found in a registry or an index.
The molecular bases of Alzheimer’s disease and other neurodegenerative disorders
Open accessAbstract
Alzheimer's disease, the cause of one of the most common types of dementia, is a brain disorder affecting the elderly and is characterized by the formation of two main protein aggregates: senile plaques and neurofibrillary tangles, which are involved in the process leading to progressive neuronal degeneration and death. Neurodegeneration in Alzheimer's disease is a pathologic condition of cells rather than an accelerated way of aging. The senile plaques are generated by a deposition in the human brain of fibrils of the beta-amyloid peptide (Abeta), a fragment derived from the proteolytic processing of the amyloid precursor protein (APP). Tau protein is the major component of paired helical filaments (PHFs), which form a compact filamentous network described as neurofibrillary tangles (NFTs). Experiments with hippocampal cells in culture have indicated a relationship between fibrillary amyloid and the cascade of molecular signals that trigger tau hyperphosphorylations. Two main protein kinases have been shown to be involved in anomalous tau phosphorylations: the cyclin-dependent kinase Cdk5 and glycogen synthase kinase GSK3beta. Cdk5 plays a critical role in brain development and is associated with neurogenesis as revealed by studies in brain cells in culture and neuroblastoma cells. Deregulation of this protein kinase as induced by extracellular amyloid loading results in tau hyperphosphorylations, thus triggering a sequence of molecular events that lead to neuronal degeneration. Inhibitors of Cdk5 and GSK3beta and antisense oligonucleotides exert protection against neuronal death. On the other hand, there is cumulative evidence from studies in cultured brain cells and on brains that oxidative stress constitutes a main factor in the modification of normal signaling pathways in neuronal cells, leading to biochemical and structural abnormalities and neurodegeneration as related to the pathogenesis of Alzheimer's disease. This review is focused on the main protein aggregates responsible for neuronal death in both sporadic and familial forms of Alzheimer's disease, as well as on the alterations in the normal signaling pathways of functional neurons directly involved in neurodegeneration. The analysis is extended to the action of neuroprotective factors including selective inhibitors of tau phosphorylating protein kinases, estrogens, and antioxidants among other molecules that apparently prevent neuronal degeneration.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“NTFs contain, as their first component, aggregates of the protein tau (τ) in a hyperphosphorylated state.”
From Multi-Target Mechanisms of Phytochemicals in Alzheimer’s Disease: Effects on Oxidative Stress, Neuroinflammation and Protein Aggregation (2022) · cites this paper as [19]
In the citing paper
“in healthy neuronal cells, following consecutive and reversible enzymatic processes of phosphorylation and dephosphorylation, it has the task of assembling and stabilizing microtubules and determining their binding with other components of the cytoskeleton [19,20].”
From Multi-Target Mechanisms of Phytochemicals in Alzheimer’s Disease: Effects on Oxidative Stress, Neuroinflammation and Protein Aggregation (2022) · cites this paper as [19]
Citations
Cites
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062
Alzheimer's Disease: Genes, Proteins, and Therapy
Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of Apoptosis
Kluck, R. M., Bossy‐Wetzel, E., Green, D. R., & Newmeyer, D. D. (1997) · Science · doi:10.1126/science.275.5303.1132 · Cited by 4,715
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051
Oxidative Stress, Glutamate, and Neurodegenerative Disorders
Coyle, J. T., & Puttfarcken, P. (1993) · Science · doi:10.1126/science.7901908 · Cited by 3,762
Excitatory Amino Acids as a Final Common Pathway for Neurologic Disorders
Epstein, F. H., Lipton, S. A., & Rosenberg, P. A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403033300907 · Cited by 2,676
Regulation of neuronal survival by the serine-threonine protein kinase Akt
Dudek, H., Datta, S. R., Franke, T. F., Birnbaum, M. J., Yao, R., Cooper, G. M., Segal, R. A., Kaplan, D. R., & Greenberg, M. E. (1997) · Science · doi:10.1126/science.275.5300.661 · Cited by 2,436
RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease
Yan, S. D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Zhao, L., Nagashima, M., Morser, J., et al. (1996) · Nature · doi:10.1038/382685a0 · Cited by 2,012
Amyloid β-peptide is produced by cultured cells during normal metabolism
Haass, C., Schlossmacher, M. G., Hung, A. Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B. L., Lieberburg, I., Koo, E. H., Schenk, D., Teplow, D. B., et al. (1992) · Nature · doi:10.1038/359322a0 · Cited by 1,921
Microtubule-associated protein tau. A component of Alzheimer paired helical filaments.
Grundke, I., Iqbal, K., Quinlan, M., Tung, Y. C., Zaidi, M. S., & Wisniewski, H. M. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38495-8 · Cited by 1,780
Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids
Seubert, P., Vigo-Pelfrey, C., Esch, F., Lee, M., Dovey, H., Davis, D., Sinha, S., Schiossmacher, M., Whaley, J., Swindlehurst, C., et al. (1992) · Nature · doi:10.1038/359325a0 · Cited by 1,731
Giasson, B. I., Duda, J. E., Murray, I. V. J., Chen, Q., Souza, J. M., Hurtig, H. I., Ischiropoulos, H., Trojanowski, J. Q., & Lee, V. M. ‐. (2000) · Science · doi:10.1126/science.290.5493.985 · Cited by 1,567
Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration
Patrick, G. N., Zukerberg, L. R., Nikolić, M., de la Monte, S. M., Dikkes, P., & Tsai, L. (1999) · Nature · doi:10.1038/45159 · Cited by 1,541
Kosik, K. S., Joachim, C. L., & Selkoe, D. J. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.11.4044 · Cited by 1,491
Iron accumulation in Alzheimer disease is a source of redox-generated free radicals
Smith, M. A., Harris, P. L. R., Sayre, L. M., & Perry, G. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9866 · Cited by 1,357
Bruijn, L. I., Becher, M. W., Lee, M. K., Anderson, K. L., Jenkins, N. A., Copeland, N. G., Sisodia, S. S., Rothstein, J. D., Borchelt, D. R., Price, D. L., et al. (1997) · Neuron · doi:10.1016/s0896-6273(00)80272-x · Cited by 1,341
MCGEER, P., & MCGEER, E. (1995) · Brain Research Reviews · doi:10.1016/0165-0173(95)00011-9 · Cited by 1,287
Widespread Peroxynitrite-Mediated Damage in Alzheimer’s Disease
Smith, M. A., Richey Harris, P. L., Sayre, L. M., Beckman, J. S., & Perry, G. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02653.1997 · Cited by 1,239
Decreased Glutamate Transport by the Brain and Spinal Cord in Amyotrophic Lateral Sclerosis
Rothstein, J. D., Martin, L. J., & Kuncl, R. W. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205283262204 · Cited by 1,197
Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity
Kitaguchi, N., Takahashi, Y., Tokushima, Y., Shiojiri, S., & Ito, H. (1988) · Nature · doi:10.1038/331530a0 · Cited by 1,083
Neurotoxicity induces cleavage of p35 to p25 by calpain
Lee, M.-S., Kwon, Y. T., Li, M., Peng, J., Friedlander, R. M., & Tsai, L. (2000) · Nature · doi:10.1038/35012636 · Cited by 1,057
Liberatore, G. T., Jackson-Lewis, V., Vukosavic, S., Mandir, A. S., Vila, M., McAuliffe, W. G., Dawson, V. L., Dawson, T. M., & Przedborski, S. (1999) · Nature Medicine · doi:10.1038/70978 · Cited by 1,046
Role of Glycogen Synthase Kinase-3 in the Phosphatidylinositol 3-Kinase/Akt Cell Survival Pathway
Pap, M., & Cooper, G. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.19929 · Cited by 1,046
Atwood, C. S., Moir, R. D., Huang, X., Scarpa, R. C., Bacarra, N. M. E., Romano, D. M., Hartshorn, M. A., Tanzi, R. E., & Bush, A. I. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.21.12817 · Cited by 1,009
Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives
Mattson, M. P. (1997) · Physiological Reviews · doi:10.1152/physrev.1997.77.4.1081 · Cited by 1,006
Oxidative Damage and Tyrosine Nitration from Peroxynitrite
Beckman, J. S. (1996) · Chemical Research in Toxicology · doi:10.1021/tx9501445 · Cited by 993
The oxidant stress hypothesis in Parkinson's disease: Evidence supporting it
Fahn, S., & Cohen, G. (1992) · Annals of Neurology · doi:10.1002/ana.410320616 · Cited by 927
p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5
Tsai, L., Delalle, I., Caviness, V. S., Chae, T. H., & Harlow, E. (1994) · Nature · doi:10.1038/371419a0 · Cited by 923
Neuroprotection against Oxidative Stress by Estrogens: Structure-Activity Relationship
Behl, C., Skutella, T., Lezoualc’h, F., Post, A., Widmann, M., Newton, C. J., & Holsboer, F. (1997) · Molecular Pharmacology · doi:10.1124/mol.51.4.535 · Cited by 757
β-amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity
Zheng, H., Jiang, M., Trumbauer, M. E., SIRINATHSINGHJI, D. J. S., Hopkins, R., Smith, D. W., HEAVENS, R. P., Dawson, G. R., Boyce, S., Conner, M. W., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90073-x · Cited by 699
Tau protein pathology in neurodegenerative diseases
Spillantini, M. G., & Goedert, M. (1998) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01337-x · Cited by 683
Aronica, S. M., Kraus, W. L., & Katzenellenbogen, B. S. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.18.8517 · Cited by 670
Evidence of neuronal oxidative damage in Alzheimer's disease.
Good, P. F., Werner, P., Hsu, A., Olanow, C. W., & Perl, D. P. (1996) · Europe PMC (PubMed Central) · Cited by 600
Estévez, A. G., Crow, J. P., Sampson, J. B., Reiter, C., Zhuang, Y., Richardson, G. J., Tarpey, M. M., Barbeito, L., & Beckman, J. S. (1999) · Science · doi:10.1126/science.286.5449.2498 · Cited by 596
Secretion of β-amyloid precursor protein cleaved at the amino terminus of the β-amyloid peptide
Seubert, P. A., Oltersdorf, T., Lee, M., Barbour, R., Blomquist, C. L., Davis, D. L., Bryant, K., Fritz, L. C., Galasko, D., Thal, L. J., et al. (1993) · Nature · doi:10.1038/361260a0 · Cited by 560
Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists
Turski, L., Bressler, K., Rettig, K.-J., Löschmann, P. A., & Wachtel, H. (1991) · Nature · doi:10.1038/349414a0 · Cited by 546
Kamal, A., Stokin, G. B., Yang, Z., Xia, C.-H., & Goldstein, L. S. B. (2000) · Neuron · doi:10.1016/s0896-6273(00)00124-0 · Cited by 544
Protein Nitration in Parkinsonʼs Disease
Good, P. F., Hsu, A., Werner, P., Perl, D. P., & Olanow, C. W. (1998) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199804000-00006 · Cited by 540
17β-Estradiol Enhances NMDA Receptor-Mediated EPSPs and Long-Term Potentiation
Foy, M. R., Xu, J., Xie, X., Brinton, R. D., Thompson, R. F., & Berger, T. W. (1999) · Journal of Neurophysiology · doi:10.1152/jn.1999.81.2.925 · Cited by 519
Hensley, K., Maidt, M. L., Yu, Z., Sang, H., Markesbery, W. R., & Floyd, R. A. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-20-08126.1998 · Cited by 508
Crow, J. P., Sampson, J. B., Zhuang, Y., Thompson, J. A., & Beckman, J. S. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69051936.x · Cited by 487
Alpha-2 macroglobulin is genetically associated with Alzheimer disease
Blacker, D., Wilcox, M. A., Laird, N. M., Rodes, L., Horvath, S. M., Go, R. C. P., Perry, R., Watson, B., Bassett, S. S., McInnis, M. G., et al. (1998) · Nature Genetics · doi:10.1038/1243 · Cited by 486
Selkoe (1999) · doi:10.1038/19866 · Cited by 468
Glutamate uptake inhibition by oxygen free radicals in rat cortical astrocytes
Volterra, A., Trotti, D., Tromba, C., FLORIDI, S., & Racagni, G. (1994) · Journal of Neuroscience · doi:10.1523/jneurosci.14-05-02924.1994 · Cited by 457
Cellular mechanisms of β-amyloid production and secretion
Sinha, S., & Lieberburg, I. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.11049 · Cited by 448
Keller, J. N., Pang, Z., Geddes, J. W., Begley, J. G., Germeyer, A., Waeg, G., & Mattson, M. P. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69010273.x · Cited by 439
Wolozin, B. L., Iwasaki, K., Vito, P., Ganjei, J. K., Lacaná, E., Sunderland, T., Zhao, B., Kusiak, J. W., Wasco, W., & D'adamio, L. (1996) · Science · doi:10.1126/science.274.5293.1710 · Cited by 425
Molecular mapping of alzheimer‐type dementia in Down's syndrome
Prasher, V. P., Farrer, M. J., Kessling, A. M., Fisher, E. M. C., West, R. J., Barber, P. C., & Butler, A. C. (1998) · Annals of Neurology · doi:10.1002/ana.410430316 · Cited by 414
Ara, J. E., Przedborski, S., Naini, A., Jackson-Lewis, V. R., Trifiletti, R. R., Horwitz, J., & Ischiropoulos, H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7659 · Cited by 414
Role of microtubule-associated proteins in the control of microtubule assembly
Maccioni, R. B., & Cambiazo, V. (1995) · Physiological Reviews · doi:10.1152/physrev.1995.75.4.835 · Cited by 413
Treatment of Alzheimer's Disease
Mayeux, R. P., & Sano, M. C. (1999) · New England Journal of Medicine · doi:10.1056/nejm199911253412207 · Cited by 393
Estrogen Modulates Neuronal Bcl‐x l Expression and β‐Amyloid‐Induced Apoptosis
Pike, C. J. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.721552.x · Cited by 387
Gong, Y. H., Parsadanian, A. S., Andreeva, A., Snider, W. D., & Elliott, J. L. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-02-00660.2000 · Cited by 387
Tau protein kinase I is essential for amyloid beta-protein-induced neurotoxicity.
Takashima, A., Noguchi, K., Sato, K., Hoshino, T., & Imahori, K. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.16.7789 · Cited by 385
Schweers, O., Mandelkow, E., Biernat, J., & Mandelkow, E. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.18.8463 · Cited by 379
Peroxynitrite Inhibits Glutamate Transporter Subtypes
Trotti, D., Rossi, D., Gjesdal, O., Levy, L. M., Racagni, G., Danbolt, N. C., & Volterra, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.11.5976 · Cited by 371
Estrogen regulates metabolism of Alzheimer amyloid beta precursor protein.
Jaffe, A. B., Toran‐Allerand, C. D., Greengard, P., & Gandy, S. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36796-0 · Cited by 363
Caspase-2 Mediates Neuronal Cell Death Induced by β-Amyloid
Troy, C. M., Rabacchi, S. A., Friedman, W., Frappier, T. F., Brown, K. R., & Shelanski, M. L. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-04-01386.2000 · Cited by 354
Akama, K. T., Albanese, C., Pestell, R. G., & Eldik, L. J. V. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.10.5795 · Cited by 345
Estévez, Á. G., Spear, N., Manuel, S. M., Radí, R., Henderson, C. E., Barbeito, L., & Beckman, J. S. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-03-00923.1998 · Cited by 344
Ahlijanian, M. K., Barrezueta, N. X., Williams, R. D., Jakowski, A. B., Kowsz, K. P., McCarthy, S. A., Coskran, T., Carlo, A. A., Seymour, P. A., Burkhardt, J. E., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.040577797 · Cited by 339
Paradis, E., Douillard, H., Koutroumanis, M., Goodyer, C. G., & LeBlanc, A. C. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-23-07533.1996 · Cited by 333
Jiang, H., Burdick, D., Glabe, C. G., Cotman, C. W., & Tenner, A. J. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.10.5050 · Cited by 330
Up-Regulated Production and Activation of the Complement System in Alzheimer's Disease Brain
Yasojima, K., Schwab, C., McGeer, E. G., & McGeer, P. L. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65340-0 · Cited by 328
Haass, C., Hung, A. Y., Selkoe, D. J., & Teplow, D. B. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32503-6 · Cited by 319
Tau domains, phosphorylation, and interactions with microtubules
Mandelkow, E.-M., Biernat, J., Drewes, G., Gustke, N., Trinczek, B., & Mandelkow, E. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00025-a · Cited by 308
Cummings, B. J., Pike, C. J., Shankle, R., & Cotman, C. W. (1996) · Neurobiology of Aging · doi:10.1016/s0197-4580(96)00170-4 · Cited by 305
Amino-terminal Deletions Enhance Aggregation of β-Amyloid Peptides in Vitro
Pike, C. J., Overman, M. J., & Cotman, C. W. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.41.23895 · Cited by 302
Selective potentiation of NMDA-induced neuronal injury following induction of astrocytic iNOS
Hewett, S. J., Csernansky, C. A., & Choi, D. W. (1994) · Neuron · doi:10.1016/0896-6273(94)90362-x · Cited by 296
Akama, K. T., & Van Eldik, L. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.11.7918 · Cited by 287
Citron, M., Diehl, T. S., Gordon, G., Biere, A. L., Seubert, P. A., & Selkoe, D. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.23.13170 · Cited by 287
Takashima, A., Honda, T., Yasutake, K., Michel, G., Murayama, O., Murayama, M., Ishiguro, K., & Yamaguchi, H. (1998) · Neuroscience Research · doi:10.1016/s0168-0102(98)00061-3 · Cited by 287
Excitotoxicity and nitric oxide in parkinson's disease pathogenesis
Beal, M. F. (1998) · Annals of Neurology · doi:10.1002/ana.410440716 · Cited by 283
Cytokine-stimulated astrocytes damage human neurons via a nitric oxide mechanism
Chao, C. C., Hu, S., Sheng, W. S., Bu, D.-F., Bukrinsky, M., & Peterson, P. K. (1996) · Glia · doi:10.1002/(sici)1098-1136(199603)16:3 · Cited by 273
Senile Dementia of the Alzheimer Type Without Neocortical Neurofibrillary Tangles
Terry, R. D., Hansen, L. A., DeTeresa, R. M., Davies, P., Tobias, H., & Katzman, R. (1987) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-198705000-00003 · Cited by 268
Abe, K., Pan, L.-H., Watanabe, M., Kato, T., & Itoyama, Y. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)12039-7 · Cited by 263
Hu, J., Akama, K. T., Krafft, G. A., Chromy, B. A., & Van Eldik, L. J. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01318-8 · Cited by 262
Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer disease
Kehoe, P. G., Russ, C., McIlroy, S., Williams, H., Holmans, P., Holmes, C., Liolitsa, D., Vahidassr, D., Powell, J., McGleenon, B., et al. (1999) · Nature Genetics · doi:10.1038/5009 · Cited by 260
Yang, F., Sun, X., Beech, W. K., Teter, B., Wu, S. S. H., Sigel, J. J., Vinters, H. V., Frautschy, S. A., & Cole, G. M. (1998) · Europe PMC (PubMed Central) · Cited by 245
Dawson, V. L., Brahmbhatt, H., Mong, J. A., & Dawson, T. M. (1994) · Neuropharmacology · doi:10.1016/0028-3908(94)90045-0 · Cited by 243
Xia, W., Zhang, J., Perez, R. G., Koo, E. H., & Selkoe, D. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.15.8208 · Cited by 240
Physiology and pathology of tau protein kinases in relation to Alzheimer's disease.
Imahori, K., & Uchida, T. (1997) · PubMed · Cited by 236
Almer, G., Vukosavić, S., Romero, N. B., & Przedborski, S. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0722415.x · Cited by 231
Harris‐White, M. E., Wang, Y., Pedigo, N. W., Hensley, K., Butterfield, D. A., & Carney, J. M. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67010277.x · Cited by 230
Inhibition of tau phosphorylating protein kinase cdk5 prevents β‐amyloid‐induced neuronal death
Alvarez, A. R., Toro, R., Cáceres, A., & Maccioni, R. B. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01279-x · Cited by 228
Smith, M. A., Sayre, L. M., Anderson, V. E., Harris, P. L. R., Beal, M. F., Kowall, N. W., & Perry, G. L. (1998) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215549804600605 · Cited by 222
Kang, D. E., Saitoh, T., Chen, X., Xia, Y., Masliah, E., Hansen, L. A., Thomas, R. G., Thal, L. J., & Katzman, R. (1997) · Neurology · doi:10.1212/wnl.49.1.56 · Cited by 211
Qiu, W. W. Q., Ferreira, A., Miller, C., Koo, E., & Selkoe, D. (1995) · Journal of Neuroscience · doi:10.1523/jneurosci.15-03-02157.1995 · Cited by 193
Paglini, M. G., Pigino, G. F., Kunda, P. E., Morfini, G. A., Maccioni, R. B., Quiroga, S., Ferreira, A., & Cáceres, A. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-23-09858.1998 · Cited by 192
Graeber, M. B., Kösel, S., Egensperger, R., Banati, R. B., Müller, U., Bise, K., Hoff, P. T., Möller, H. ‐., Fujisawa, K., & Mehraein, P. (1997) · Neurogenetics · doi:10.1007/s100480050011 · Cited by 189
Su, J. H., Deng, G., & Cotman, C. W. (1997) · Brain Research · doi:10.1016/s0006-8993(97)81703-9 · Cited by 175
Maccioni, R. B., Carola Otth, L., Concha, I. I., & Muñoz, J. P. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02024.x · Cited by 173
Synaptogenic action of sex steroids in developing and adult neuroendocrine brain
Matsumoto, A. (1991) · Psychoneuroendocrinology · doi:10.1016/0306-4530(91)90069-6 · Cited by 171
Cognitive deficits of men and women with Alzheimer's disease
Henderson, V. W., & Buckwalter, J. G. (1994) · Neurology · doi:10.1212/wnl.44.1.90 · Cited by 170
Potentiation of GSK-3-catalyzed Alzheimer-like phosphorylation of human tau by cdk5
Sengupta, A., Wu, Q., Grundke, I., Iqbal, K., & Singh, T. J. (1997) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006883924775 · Cited by 160
The molecular and genetic basis of AD: The end of the beginning
Rosenberg, R. N. (2000) · Neurology · doi:10.1212/wnl.54.11.2045 · Cited by 158
Tanaka, S., Nakamura, S., Ueda, K., Kameyama, M., Shiojiri, S., Takahashi, Y., Kitaguchi, N., & Ito, H. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)80273-0 · Cited by 156
Histochemical detection of 4-hydroxynonenal protein in Alzheimer amyloid
Ando, Y., Brännström, T., Uchida, K., Nyhlin, N., Näsman, B., Suhr, O. B., Yamashita, T., Olsson, T., Salhy, M. E., Uchino, M., et al. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00042-2 · Cited by 152
Ishiguro, K., Omori, A., Takamatsu, M., Sato, K., Arioka, M., Uchida, T., & Imahori, K. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90839-y · Cited by 151
Rogaeva, E. A. (1998) · JAMA · doi:10.1001/jama.280.7.614 · Cited by 150
Neve, R. L., McPhie, D. L., & Chen, Y. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02869-9 · Cited by 140
MacManus, A., Ramsden, M., Murray, M., Henderson, Z., Pearson, H. A., & Campbell, V. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.7.4713 · Cited by 137
Reactive astrocytes are widespread in the cortical gray matter of amyotrophic lateral sclerosis
Nagy, D., Kato, T., & Kushner, P. D. (1994) · Journal of Neuroscience Research · doi:10.1002/jnr.490380312 · Cited by 131
Pigino, G. F., Paglini, M. G., Ulloa, L., Ávila, J., & Cáceres, A. (1997) · Journal of Cell Science · doi:10.1242/jcs.110.2.257 · Cited by 130
Amyloid β-peptide and oxidative cellular injury in Alzheimer’s disease
Mark, R. J., Blanc, E. M., & Mattson, M. P. (1996) · Molecular Neurobiology · doi:10.1007/bf02755589 · Cited by 129
Microtubule-associated polypeptides tau are altered in Alzheimer paired helical filaments
Grundke, I., VORBRODT, A. W., Iqbal, K., Tung, Y. C., Wang, G. P., & Wisniewski, H. M. (1988) · Molecular Brain Research · doi:10.1016/0169-328x(88)90017-4 · Cited by 128
Kritzer, M. F., & Kohama, S. G. (1999) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19990705)409:3 · Cited by 126
Zheng, P., Eastman, J. F., Pol, S. V., & Pimplikar, S. W. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14745 · Cited by 126
Alvarez, A. R., Muñoz, J. P., & Maccioni, R. B. (2001) · Experimental Cell Research · doi:10.1006/excr.2001.5152 · Cited by 125
Arendt, T., Brückner, M. K., Gertz, H.-J., & Marcova, L. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00509-5 · Cited by 122
Interaction of Alzheimer's Presenilin-1 and Presenilin-2 with Bcl-XL
Passer, B. J., Pellegrini, L., Vito, P., Ganjei, J. K., & D'adamio, L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.34.24007 · Cited by 107
Does Oxidative Stress Participate in Nerve Cell Death in Parkinson’s Disease?
Hirsch, É. C., & Hirsch, É. C. (2008) · European Neurology · doi:10.1159/000118538 · Cited by 106
Mitochondrial function in Parkinson's disease
Schapira, A. H. V., Mann, V. M., Cooper, J. A. D., Krige, D., Jenner, P. G., & MARSDEN, C. D. (1992) · Annals of Neurology · doi:10.1002/ana.410320720 · Cited by 106
The inhibitory effects of β-amyloid on glutamate and glucose uptakes by cultured astrocytes
Parpura‐Gill, A., Beitz, D. C., & Uemura, E. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00043-7 · Cited by 105
Head, E., Azizeh, B. Y., Lott, I. T., Tenner, A. J., Cotman, C. W., & Cribbs, D. H. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0380 · Cited by 103
Gridley, K. E., Green, P. S., & Simpkins, J. W. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.5.874 · Cited by 100
Induction of Nitric Oxide Synthase Inhibits Gap Junction Permeability in Cultured Rat Astrocytes
Bolaños, J. P., & Medina, J. M. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66052091.x · Cited by 97
Ferritin is associated with the aberrant tau filaments present in progressive supranuclear palsy.
Pérez, M., Valpuesta, J., de Garcini, E. M., Quintana, C., Arrasate, M., Carrascosa, J. L., Rábano, A., de Yébenes, J. G., & Ávila, J. (1998) · Europe PMC (PubMed Central) · Cited by 94
Association at LRP gene locus with sporadic late-onset Alzheimer's disease
Lambert, J., Vrièze, F. W., Amouyel, P., & Chartier‐Harlin, M. (1998) · The Lancet · doi:10.1016/s0140-6736(05)78749-3 · Cited by 92
Bleomycin hydrolase is associated with risk of sporadic Alzheimer's disease
Montoya, S. E., Aston, C. E., DeKosky, S. T., Kamboh, M. I., Lazo, J. S., & Ferrell, R. E. (1998) · Nature Genetics · doi:10.1038/ng0398-211 · Cited by 91
Shughrue, P. J. (1998) · Endocrinology · doi:10.1210/en.139.12.5267 · Cited by 91
Michel, G., Mercken, M., Murayama, M., Noguchi, K., Ishiguro, K., Imahori, K., & Takashima, A. (1998) · Biochimica et Biophysica Acta · doi:10.1016/s0304-4165(97)00139-6 · Cited by 89
Oxidative metabolism deficiencies in brains of patients with Alzheimer's disease
Hoyer, S. (1996) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1996.tb05868.x · Cited by 88
Ferrante, R. J., Hantraye, P., Brouillet, E., & Beal, M. F. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01166-x · Cited by 77
Amyloid β peptides mediate hypoxic augmentation of Ca2+ channels
Green, K. N., & Peers, C. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00338.x · Cited by 74
ALZHEIMER'S DISEASE AND TAU PROTEINS
Brion, J., Flament-Durand, J., & Dustin, P. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90495-2 · Cited by 72
Spear, N., Estévez, Á. G., Barbeito, L., Beckman, J. S., & Johnson, G. V. W. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69010053.x · Cited by 70
Ik, C., Chung, Y. H., Shin, C. M., Shin, D. H., Kim, Y. S., Gurney, M. E., & Lee, K. W. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02302-1 · Cited by 67
Glutamate uptake is decreased tardively in the spinal cord of FALS mice
Canton, T., Pratt, J., Stutzmann, J. M., Impérato, A., & Boireau, A. (1998) · Neuroreport · doi:10.1097/00001756-199803300-00001 · Cited by 65
Cross, D. C., Vial, C., & Maccioni, R. B. (1993) · Journal of Cell Science · doi:10.1242/jcs.105.1.51 · Cited by 59
Ik, C., Kim, J. M., Shin, D. H., Kim, Y. S., Kim, J., Gurney, M. E., & Lee, K. W. (1998) · Neuroreport · doi:10.1097/00001756-199805110-00047 · Cited by 43
Lack of association of the α2-macroglobulin locus on chromosome 12 in AD
GIBSON, A. M., Singleton, A., Smith, G., Woodward, R., McKeith, I. G., Perry, R. H., Ince, P. G., Ballard, C. G., Edwardson, J. A., & Morris, C. M. (2000) · Neurology · doi:10.1212/wnl.54.2.433 · Cited by 43
Saragoni, L., Hernández, P., & Maccioni, R. B. (2000) · Neurochemical Research · doi:10.1023/a:1007587315630 · Cited by 42
Mechanisms of Neurodegenerative Disorders
Wolozin, B. L., & Behl, C. (2000) · Archives of Neurology · doi:10.1001/archneur.57.6.801 · Cited by 41
Matsuno, A., Takekoshi, S., Sanno, N., Utsunomiya, H., Ohsugi, Y., Saito, N., Kanemitsu, H., Tamura, A., Nagashima, T., OSAMURA, R. Y., et al. (1997) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215549704500605 · Cited by 37
Neurodegeneration in Alzheimer disease
Kusiak, J. W., Izzo, J. A., & Zhao, B. (1996) · Molecular and Chemical Neuropathology · doi:10.1007/bf02815217 · Cited by 35
Maizels, E. T., Miller, J. B., Cutler, R. E., Jackiw, V., Carney, E. M., Mizuno, K., Ohno, S., & Hunzicker-Dunn, M. E. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41892-3 · Cited by 33
Stimulation of Membrane-Bound Guanylate Cyclase Activity by 17-β Estradiol
Chen, Z., Yu, L. P. C., & Chang, C.-H. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9716 · Cited by 32
The butyrylcholinesterase K variant and susceptibility to Alzheimer's disease.
Kehoe, P. G., Williams, H. J., Holmans, P., Wilcock, G. K., Cairns, N. J., Neal, J. W., & Owen, M. J. (1998) · Journal of Medical Genetics · doi:10.1136/jmg.35.12.1034 · Cited by 29
Presenilin Function in APP Processing
Annaert, W. G., Cupers, P., Säftig, P., & Strooper, B. D. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06917.x · Cited by 27
Srivastava, R. A. K., Krul, E. S., Lin, R. C., & Schonfeld, G. (1997) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006896131186 · Cited by 26
Paired helical filament morphology varies with intracellular location in Alzheimer's disease brain
Kurt, M. A., Davies, D. C., & Kidd, M. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00876-8 · Cited by 25
Presenilins, β-amyloid precursor protein and the molecular basis of Alzheimer's disease
Selkoe, D. J. (2001) · Clinical Neuroscience Research · doi:10.1016/s1566-2772(00)00016-5 · Cited by 24
Muñoz, J. P., Alvarez, A. R., & Maccioni, R. B. (2000) · Neuroreport · doi:10.1097/00001756-200008210-00025 · Cited by 21
Protective action of idebenone against excitotoxic degeneration in cultured cortical neurons
Bruno, V., Battaglia, G., Copani, A., Sortino, M. A., Canonico, P. L., & Nicoletti, F. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90757-9 · Cited by 19
Burke, R. E. (1999) · Humana Press eBooks · doi:10.1007/978-1-4612-1602-5_22 · Cited by 12
Research works printed but not linked: 2
- Catania, 2001, Expression and localization of cyclin-dependent kinase 5 in apoptotic human glioma cells, Neurooncology, 3, 89
- Saez, 1990, Gap junctions, In Vitro Toxicol, 3, 69
Cited by
Sorted by citations
GSK-3: tricks of the trade for a multi-tasking kinase
Doble, B. W., & Woodgett, J. R. (2003) · Journal of Cell Science · doi:10.1242/jcs.00384 · Cited by 2,084
Oxidative Stress and the Pathogenesis of Alzheimer's Disease
Zhao, Y., & Zhao, B. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/316523 · Cited by 855
Expression of Nrf2 in Neurodegenerative Diseases
Ramsey, C. P., Glass, C. A., Montgomery, M. B., Lindl, K. A., Ritson, G. P., Chia, L. A., Hamilton, R. L., Chu, C. T., & Jordan-Sciutto, K. L. (2007) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/nen.0b013e31802d6da9 · Cited by 760
The dynamic nature of Bruch's membrane
Booij, J. C., Baas, D. C., Beisekeeva, J., Gorgels, T. G. M. F., & Bergen, A. A. B. (2010) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2009.08.003 · Cited by 581
Moreno, S., Vecchioli, S. F., & Cerù, M. P. (2003) · Neuroscience · doi:10.1016/j.neuroscience.2003.08.064 · Cited by 595
Metadata
- Authors
- Maccioni, R. B., Muñoz, J. P., & Barbeito, L.
- Affiliations
- University of Chile (CL)
- Instituto de Investigaciones Biológicas Clemente Estable (UY)
- Corresponding author
- Maccioni, Ricardo B
- Venue
- Archives of Medical Research
- Publisher
- Elsevier BV
- Published
- 2001-09
- Volume
- 32
- Issue
- 5
- Pages
- 367-381
- ISSN
- 0066-6769 (ISSN-L)
- 0188-4409
- OpenAlex
- W1985122965
- Cited by
- 474
- References
- 150
- Citations by year
- 2026: 8 · 2025: 12 · 2024: 24 · 2023: 8 · 2022: 13 · 2021: 14 · 2020: 17 · 2019: 19 · 2018: 20 · 2017: 28 · 2016: 17 · 2015: 17 · 2014: 19 · 2013: 22 · 2012: 30
- FWCI
- 2.49
- Type
- journal article
- Language
- en
- Open access
- green
- americanae.aecid.es
- Licence
- Locations
- Archives of Medical Research (publishedVersion)
- PubMed (publishedVersion)
- Americanae (AECID Library) (submittedVersion, other-oa)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, neurodegeneration, amyloid plaques, neurofibrillary tangles, amyloid-beta, amyloid precursor protein, tau protein, tau hyperphosphorylation, cyclin-dependent kinase 5, GSK3β, oxidative stress, neuronal cell death, neuroprotective factors, estrogen, antioxidants, protein kinase inhibitors, antisense oligonucleotides, dementia
- MeSH terms
- Adult, Aged, alpha-Macroglobulins, Alzheimer Disease, Amino Acid Sequence, Apolipoproteins E, Astrocytes, Calcium, Estrogens, Humans, Membrane Proteins, Memory Disorders, Middle Aged, Molecular Sequence Data, Nerve Tissue Proteins, Neurons, Neurotoxins, Nitric Oxide, Parkinson Disease, Protein Processing, Post-Translational, Signal Transduction, Motor Neuron Disease, Amyloid beta-Protein Precursor, Neurofibrillary Tangles, tau Proteins, Cell Death, Age of Onset, Oxidative Stress, Neurodegenerative Diseases, Caspases, Presenilin-1, Presenilin-2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review